Case activity for Boehringer Ingelheim Corp. vs Hec Pharm Co. Ltd. on May 29

The U.S. District Court for the Eastern District of Pennsylvania reported the following activities in the suit brought by Boehringer Ingelheim Corp., Boehringer Ingelheim International GMBH, Boehringer Ingelheim Pharma GMBH & Co. KG and Boehringer Ingelheim Pharmaceuticals Inc. against Hec Pharm Co. Ltd. and Hec Pharm USA on May 29.

'Complaint Against Hec Pharm Co., Ltd., Hec Pharm Usa ( Filing Fee $ 400 Receipt Number 0313-14322511.), Filed By Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma Gmbh & Co. Kg, Boehringer Ingelheim Corporation, Boehringer Ingelheim International Gmbh. (attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Civil Cover Sheet, # 5 Designation Form, # 6 Case Management Track Form, # 7 Report On The Filing Or Determination Of An Action Regarding A Patent Or Trademark)(pizzi, Peter)'

'Disclosure Statement Form Pursuant To Frcp 7.1 By Boehringer Ingelheim Corporation, Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Gmbh & Co. Kg, Boehringer Ingelheim Pharmaceuticals Inc..(pizzi, Peter)'

Case number 2:20-cv-02545 was filed in the U.S. District Court for the Eastern District of Pennsylvania on May 29.